scholarly journals An oxaliplatin(iv) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment

2018 ◽  
Vol 54 (90) ◽  
pp. 12762-12765 ◽  
Author(s):  
Wei Qi Lim ◽  
Soo Zeng Fiona Phua ◽  
Hongzhong Chen ◽  
Yanli Zhao

A two-component supramolecular prodrug nanocarrier fabricated via self-assembly presents redox-responsive drug release with cancer cell-targeting capability, showing enhanced efficiency for colorectal cancer treatment.

RSC Advances ◽  
2021 ◽  
Vol 11 (26) ◽  
pp. 16131-16141
Author(s):  
Manali Haniti Mohd-Zahid ◽  
Siti Nadiah Zulkifli ◽  
Che Azurahanim Che Abdullah ◽  
JitKang Lim ◽  
Sharida Fakurazi ◽  
...  

5-FU-PEGylated AuNPs-CD133 is designed to improve specific targeting of 5-FU against colorectal cancer cells which abundantly express CD133.


RSC Advances ◽  
2021 ◽  
Vol 11 (9) ◽  
pp. 4952-4957
Author(s):  
Valeria Tagliavini ◽  
Claudia Honisch ◽  
Simona Serratì ◽  
Amalia Azzariti ◽  
Marcella Bonchio ◽  
...  

The introduction of a tailored hydrophilic/anionic spacer in an Anderson–Evans polyoxometalate, bis-conjugated with demobensin-1 peptide, fosters self-assembly into fibrillary nanostructures and an unprecedented cancer cell targeting ability.


2018 ◽  
Vol 5 (1) ◽  
pp. 170986 ◽  
Author(s):  
Yang Zhang ◽  
Juan Xu

This paper proposes a novel type of multifunctional envelope-type mesoporous silica nanoparticle (MSN) to achieve cancer cell targeting and drug-controlled release. In this system, MSNs were first modified by active targeting moiety hyaluronic acid (HA) for breast cancer cell targeting and hyaluronidases (Hyal)-induced intracellular drug release. Then gelatin, a proteinaceous biopolymer, was grafted onto the MSNs to form a capping layer via glutaraldehyde-mediated cross-linking. To shield against unspecific uptake of cells and prolong circulation time, the nanoparticles were further decorated with poly(ethylene glycol) polymers (PEG) to obtain MSN@HA-gelatin-PEG (MHGP). Doxorubicin (DOX), as a model drug, was loaded into PEMSN to assess the breast cancer cell targeting and drug release behaviours. In vitro study revealed that PEG chains protect the targeting ligand and shield against normal cells. After reaching the breast cancer cells, MMP-2 overpressed by cells hydrolyses gelatin layer to deshield PEG and switch on the function of HA. As a result, DOX-loaded MHGP was selectively trapped by cancer cells through HA receptor-mediated endocytosis and subsequently release DOX due to Hyal-catalysed degradation of HA. This system presents successful bienzyme-responsive targeting drug delivery in an optimal fashion and provides potential applications for targeted cancer therapy.


Polymers ◽  
2017 ◽  
Vol 9 (12) ◽  
pp. 213 ◽  
Author(s):  
Yu-Han Wen ◽  
Tsung-Ying Lee ◽  
Ping-Chuan Fu ◽  
Chun-Liang Lo ◽  
Yi-Ting Chiang

2019 ◽  
Vol 33 (6) ◽  
pp. 551-552
Author(s):  
Mateusz Rubinkiewicz ◽  
Michał Pędziwiatr

Sign in / Sign up

Export Citation Format

Share Document